JPRN-UMIN000023416
Not Yet Recruiting
Phase 2
Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas - Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas
agoya University Graduate School of Medicine, Department of Radiology0 sites40 target enrollmentAugust 31, 2016
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- agoya University Graduate School of Medicine, Department of Radiology
- Enrollment
- 40
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) unable to take oral S\-1; (2\) with a history of severe allergy; (3\) severe clinical infection; (4\) with active double cancer including simultaneous cancer or metachronous cancer within 5 years, except for in situ or intramucosal carcinoma; (5\) being pregnant or breast feeding; (6\) with mental disease interfering participating the trial; (7\) with severe bone marrow dysfunction; (8\) with the history of kidney disease, such as getting dialysis; (9\) with the history of severe liver disease; (10\)with the history of severe lung disease, such as interstitial pneumonia of pulmonary fibrosis; (11\) with the history of collagen disease; (12\) with uncontrolled diabetes mellitus or insulin\-dependent diabetes mellitus; (13\) with uncontrolled hypertension; (14\) cardiovascular diseases with clinical significance, such as heart failure, history of myocardial infarction or angina in the past half year; (15\) taking drugs as follows; other pyrimidine compound\- anticancer drug or flucytosine ; (16\) jugged as inadequate case by doctor in charge.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70
Withdrawn
N/A
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasmsKCT0003478CC Hospital27
Not Yet Recruiting
Phase 1
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.eoplasm of the external auditory canal and middle earJPRN-UMIN000013304Kobe University Hospital12